肝炎患者-话题@MedSci

#肝炎患者#

130篇内容 | 3186人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1807846, encodeId=4bd0180e846b0, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=Adv Clin Exp Med：乙型肝炎病毒逆转录酶的突变与慢性乙型肝炎患者的肝病严重程度相关, objectType=article, longId=129625, objectId=c6b31296257e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6b31296257e, replyNumber=0, likeNumber=68, createdTime=2018-12-25, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6b31296257e, moduleTitle=Adv Clin Exp Med：乙型肝炎病毒逆转录酶的突变与慢性乙型肝炎患者的肝病严重程度相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6b31296257e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807864, encodeId=f559180e86488, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=Clin Gastroenterology H：粒细胞集落刺激因子联合N-乙酰半胱氨酸治疗重症酒精性肝炎患者的疗效分析, objectType=article, longId=150367, objectId=d8e315036e52, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8e315036e52, replyNumber=0, likeNumber=71, createdTime=2018-11-13, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8e315036e52, moduleTitle=Clin Gastroenterology H：粒细胞集落刺激因子联合N-乙酰半胱氨酸治疗重症酒精性肝炎患者的疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8e315036e52)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807834, encodeId=5133180e834ab, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=SCI REP：循环miR-210和miR-22结合ALT预测慢性乙型肝炎患者进行IFN-α治疗的病毒学应答!, objectType=article, longId=120238, objectId=b0771202389f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0771202389f, replyNumber=0, likeNumber=53, createdTime=2018-08-09, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0771202389f, moduleTitle=SCI REP：循环miR-210和miR-22结合ALT预测慢性乙型肝炎患者进行IFN-α治疗的病毒学应答!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0771202389f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807837, encodeId=3508180e83718, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=Hepatology：乙型肝炎患者的肝活检显示特定的micro RNA的参与病毒持续复制和肝细胞损伤等过程, objectType=article, longId=122446, objectId=3bf21224467f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bf21224467f, replyNumber=0, likeNumber=54, createdTime=2018-05-21, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bf21224467f, moduleTitle=Hepatology：乙型肝炎患者的肝活检显示特定的micro RNA的参与病毒持续复制和肝细胞损伤等过程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3bf21224467f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807840, encodeId=eae2180e840b3, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=Liver Int：在中国乙型肝炎患者中，比较了17种肝纤维化非侵入性方法的优劣, objectType=article, longId=127312, objectId=4e6d12e3127d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e6d12e3127d, replyNumber=0, likeNumber=68, createdTime=2018-12-10, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e6d12e3127d, moduleTitle=Liver Int：在中国乙型肝炎患者中，比较了17种肝纤维化非侵入性方法的优劣, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e6d12e3127d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807836, encodeId=daf6180e836dc, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=Hepatol：完全生化缓解与瞬时弹性成像可检测自身免疫性肝炎患者疾病进展, objectType=article, longId=121944, objectId=fabf121944b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fabf121944b1, replyNumber=0, likeNumber=90, createdTime=2018-02-17, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fabf121944b1, moduleTitle=Hepatol：完全生化缓解与瞬时弹性成像可检测自身免疫性肝炎患者疾病进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fabf121944b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807857, encodeId=8368180e857aa, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=J Viral Hepat：埃及丙型肝炎患者采用DAA治疗后，肝癌复发率增加, objectType=article, longId=140111, objectId=33241401119a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33241401119a, replyNumber=0, likeNumber=69, createdTime=2018-06-18, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33241401119a, moduleTitle=J Viral Hepat：埃及丙型肝炎患者采用DAA治疗后，肝癌复发率增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33241401119a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807843, encodeId=48ea180e8435b, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=Gastroenterology：TLR7兴奋剂—GS-9620，增加了慢性乙型肝炎患者HBV特异性T细胞和自然杀伤细胞的反应, objectType=article, longId=128450, objectId=3188128450b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3188128450b5, replyNumber=0, likeNumber=76, createdTime=2018-07-07, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3188128450b5, moduleTitle=Gastroenterology：TLR7兴奋剂—GS-9620，增加了慢性乙型肝炎患者HBV特异性T细胞和自然杀伤细胞的反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3188128450b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807850, encodeId=142d180e8500c, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=J Viral Hepat：既往HBV感染影响增加了慢性丙型肝炎患者不良肝脏结果的风险, objectType=article, longId=133820, objectId=d2d11338202c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2d11338202c, replyNumber=0, likeNumber=91, createdTime=2019-01-28, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2d11338202c, moduleTitle=J Viral Hepat：既往HBV感染影响增加了慢性丙型肝炎患者不良肝脏结果的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2d11338202c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807852, encodeId=ec5b180e852ce, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=Liver Int：在慢性乙型肝炎患者中，FibroStage是诊断显著纤维化、晚期纤维化和肝硬化的较好模型, objectType=article, longId=135700, objectId=2777135e00dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2777135e00dc, replyNumber=0, likeNumber=62, createdTime=2018-10-08, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2777135e00dc, moduleTitle=Liver Int：在慢性乙型肝炎患者中，FibroStage是诊断显著纤维化、晚期纤维化和肝硬化的较好模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2777135e00dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807845, encodeId=6676180e84599, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=Dig Liver Dis：一新型的非侵入性指标，用于预测慢性乙型肝炎患者中度至重度纤维化, objectType=article, longId=129241, objectId=16c512924197, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16c512924197, replyNumber=0, likeNumber=64, createdTime=2018-06-10, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16c512924197, moduleTitle=Dig Liver Dis：一新型的非侵入性指标，用于预测慢性乙型肝炎患者中度至重度纤维化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16c512924197)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807828, encodeId=d1f4180e828be, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=Hepatology：HBeAg阴性的慢性乙型肝炎患者停用口服抗病毒药物后的复发, objectType=article, longId=112444, objectId=1e7611244454, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e7611244454, replyNumber=0, likeNumber=80, createdTime=2018-03-03, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e7611244454, moduleTitle=Hepatology：HBeAg阴性的慢性乙型肝炎患者停用口服抗病毒药物后的复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e7611244454)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807835, encodeId=a3a1180e835e7, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=J Gastroenterol Hepatol：HBV与HCV联合感染阻断慢性丙型肝炎患者血小板计数恢复, objectType=article, longId=121755, objectId=20a1121e55f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20a1121e55f7, replyNumber=0, likeNumber=59, createdTime=2018-06-02, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20a1121e55f7, moduleTitle=J Gastroenterol Hepatol：HBV与HCV联合感染阻断慢性丙型肝炎患者血小板计数恢复, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20a1121e55f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807854, encodeId=5eec180e85472, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=J Viral Hepat：抗病毒治疗后获得病毒抑制的慢性乙型肝炎患者与非活性期慢性乙型肝炎患者间整体存活率的比较, objectType=article, longId=137872, objectId=094213e872ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=094213e872ba, replyNumber=0, likeNumber=66, createdTime=2019-03-23, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=094213e872ba, moduleTitle=J Viral Hepat：抗病毒治疗后获得病毒抑制的慢性乙型肝炎患者与非活性期慢性乙型肝炎患者间整体存活率的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=094213e872ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807851, encodeId=d4f2180e851c8, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=J Viral Hepat肝硬化、高龄、较高的身体质量指数是获得持续病毒学应答的慢性丙型肝炎患者的危险因素, objectType=article, longId=135563, objectId=10cc1355633a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10cc1355633a, replyNumber=0, likeNumber=85, createdTime=2019-01-06, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10cc1355633a, moduleTitle=J Viral Hepat肝硬化、高龄、较高的身体质量指数是获得持续病毒学应答的慢性丙型肝炎患者的危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10cc1355633a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807842, encodeId=d4dc180e8421f, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=Am J Gastroenterol：黑人种族是自身免疫性肝炎患者住院治疗期间发生死亡的独立预测因素, objectType=article, longId=128449, objectId=d9a812844953, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9a812844953, replyNumber=0, likeNumber=73, createdTime=2018-10-17, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9a812844953, moduleTitle=Am J Gastroenterol：黑人种族是自身免疫性肝炎患者住院治疗期间发生死亡的独立预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9a812844953)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807839, encodeId=8dbe180e83957, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=Aliment Pharm Ther：多学科讨论：慢性病毒性肝炎患者使用他汀获益大, objectType=article, longId=124721, objectId=e3cb124e218e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3cb124e218e, replyNumber=0, likeNumber=60, createdTime=2018-09-09, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3cb124e218e, moduleTitle=Aliment Pharm Ther：多学科讨论：慢性病毒性肝炎患者使用他汀获益大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3cb124e218e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807832, encodeId=522f180e83285, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=Eur J Gastroenterol Hepatol：Sofosbuvir、daclatasvir联合利巴韦林治疗改善慢性丙型肝炎患者肝功能, objectType=article, longId=114804, objectId=e5ab11480454, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5ab11480454, replyNumber=0, likeNumber=76, createdTime=2018-05-02, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5ab11480454, moduleTitle=Eur J Gastroenterol Hepatol：Sofosbuvir、daclatasvir联合利巴韦林治疗改善慢性丙型肝炎患者肝功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5ab11480454)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807849, encodeId=f3f6180e849d9, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=Clin Transl Gastroenterol：慢性乙型肝炎患者并发症增加, objectType=article, longId=133569, objectId=65a013356935, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65a013356935, replyNumber=0, likeNumber=81, createdTime=2018-09-28, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65a013356935, moduleTitle=Clin Transl Gastroenterol：慢性乙型肝炎患者并发症增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65a013356935)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807844, encodeId=23ea180e8442f, content=<a href='/topic/show?id=dd7d8124144' target=_blank style='color:#2F92EE;'>#肝炎患者#</a>, objectTitle=Liver Int：慢性乙型肝炎患者血清丙氨酸氨基转移酶水平及肝脏疾病相关死亡率的关系, objectType=article, longId=128578, objectId=fd1d1285e8c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd1d1285e8c8, replyNumber=0, likeNumber=69, createdTime=2018-12-01, rootId=0, userName=huiwelcome, userId=cd0d217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd1d1285e8c8, moduleTitle=Liver Int：慢性乙型肝炎患者血清丙氨酸氨基转移酶水平及肝脏疾病相关死亡率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd1d1285e8c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肝炎患者

2020-05-29

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

Adv Clin Exp Med：乙型肝炎病毒逆转录酶的突变与慢性乙型肝炎患者的肝病严重程度相关

2018-12-25

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

Clin Gastroenterology H：粒细胞集落刺激因子联合N-乙酰半胱氨酸治疗重症酒精性肝炎患者的疗效分析

2018-11-13

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

SCI REP：循环miR-210和miR-22结合ALT预测慢性乙型肝炎患者进行IFN-α治疗的病毒学应答!

2018-08-09

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

Hepatology：乙型肝炎患者的肝活检显示特定的micro RNA的参与病毒持续复制和肝细胞损伤等过程

2018-05-21

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

Liver Int：在中国乙型肝炎患者中，比较了17种肝纤维化非侵入性方法的优劣

2018-12-10

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

Hepatol：完全生化缓解与瞬时弹性成像可检测自身免疫性肝炎患者疾病进展

2018-02-17

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

J Viral Hepat：埃及丙型肝炎患者采用DAA治疗后，肝癌复发率增加

2018-06-18

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

Gastroenterology：TLR7兴奋剂—GS-9620，增加了慢性乙型肝炎患者HBV特异性T细胞和自然杀伤细胞的反应

2018-07-07

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

J Viral Hepat：既往HBV感染影响增加了慢性丙型肝炎患者不良肝脏结果的风险

2019-01-28

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

Liver Int：在慢性乙型肝炎患者中，FibroStage是诊断显著纤维化、晚期纤维化和肝硬化的较好模型

2018-10-08

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

Dig Liver Dis：一新型的非侵入性指标，用于预测慢性乙型肝炎患者中度至重度纤维化

2018-06-10

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

Hepatology：HBeAg阴性的慢性乙型肝炎患者停用口服抗病毒药物后的复发

2018-03-03

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

J Gastroenterol Hepatol：HBV与HCV联合感染阻断慢性丙型肝炎患者血小板计数恢复

2018-06-02

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

J Viral Hepat：抗病毒治疗后获得病毒抑制的慢性乙型肝炎患者与非活性期慢性乙型肝炎患者间整体存活率的比较

2019-03-23

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

J Viral Hepat肝硬化、高龄、较高的身体质量指数是获得持续病毒学应答的慢性丙型肝炎患者的危险因素

2019-01-06

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

Am J Gastroenterol：黑人种族是自身免疫性肝炎患者住院治疗期间发生死亡的独立预测因素

2018-10-17

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

Aliment Pharm Ther：多学科讨论：慢性病毒性肝炎患者使用他汀获益大

2018-09-09

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

Eur J Gastroenterol Hepatol：Sofosbuvir、daclatasvir联合利巴韦林治疗改善慢性丙型肝炎患者肝功能

2018-05-02

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

Clin Transl Gastroenterol：慢性乙型肝炎患者并发症增加

2018-09-28

huiwelcome (审核中...)

前往app查看评论内容

#肝炎患者#

Liver Int：慢性乙型肝炎患者血清丙氨酸氨基转移酶水平及肝脏疾病相关死亡率的关系

2018-12-01

科室
- - 订阅+
  - 更多科室
工具
服务